Millenia Diagnostics, Inc. is a privately held company that develops, manufactures, and transfers technology of diagnostic tests in a variety of technology platforms.

Applications of the company's products include detection of viral infections, hormones, drugs of abuse, therapeutic drugs, cardiac markers, food quality/microbiology, cancer markers, and parasitic infections in samples as diverse as fecal, plasma, serum, whole blood, nasal aspirate, and urine.

Danny Levenson, President, Chief Executive Officer, Millenia Diagnostics, Inc.

As president and founder of Millenia Diagnostics, Danny oversees development, manufacturing and technology transfer of diagnostic tests in a variety of technology platforms. Millenia Diagnostics, Inc. is a privately held company that produces high quality specialty diagnostics. Danny has spent the last twelve years developing and bringing to market diagnostic test technology aimed at detecting infectious diseases. Danny founded Millenia Diagnostics in 2000, which was incorporated three years later. His skills include ELISA development and manufacture, lateral flow development and manufacture, and regulatory affairs. Danny holds a Bachelor of Science degree in biology with an emphasis in chemistry from San Diego State University.